Awards Archives - Boston Life Sciences Times

Ginkgo Bioworks Narrows Third-Quarter Loss to $41 Million, Secures Autonomous Lab Deal With Novo

November 6, 2026

Two Cambridge MedTech Companies Named Finalists in MedTech Innovator’s 2026 Grand Prize Competition

November 5, 2026

Insulet Third-Quarter Profit Jumps 61% to $141.1 Million as Revenue Climbs to $842 Million

November 4, 2026

THIS WEEK'S STORIES

Karyopharm Therapeutics Files for Chapter 11 Bankruptcy, Announces Planned Merger with Ayrmid

November 2, 2026

Corista Completes 250 TB Digital Pathology Migration for Major California Medical Center

November 4, 2026

Zai Lab Reports 40% Tumor Response Rate in Clinical Trial of Experimental Neuroendocrine Cancer Treatment

November 5, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Awards

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

Call for Nominations: 2025 Life Sciences Times Awards to Honor Innovation and Impact Across the Industry

USM Honors College Biological Sciences Student Awarded Prestigious Goldwater Scholarship

Most Read

Agenus Reports 51% of Colorectal Cancer Patients Survived at Least 18 Months Following Experimental Immunotherapy

Verastem Oncology Narrows Third-Quarter Loss to $74.7 Million, Advances KRAS-Targeted Cancer Drug Toward Phase 3 Trials

Tandem Diabetes Care Appoints Jeannette Bankes as CEO, Succeeding John Sheridan

Sarepta Therapeutics Narrows Third-Quarter Loss to $28.5 Million, Advances Rare Disease Drug Programs

EDITOR PICKS

Ginkgo Bioworks Narrows Third-Quarter Loss to $41 Million, Secures Autonomous Lab Deal With Novo

Two Cambridge MedTech Companies Named Finalists in MedTech Innovator’s 2026 Grand Prize Competition

Insulet Third-Quarter Profit Jumps 61% to $141.1 Million as Revenue Climbs to $842 Million

THIS WEEK'S STORIES

Karyopharm Therapeutics Files for Chapter 11 Bankruptcy, Announces Planned Merger with Ayrmid

Corista Completes 250 TB Digital Pathology Migration for Major California Medical Center

Zai Lab Reports 40% Tumor Response Rate in Clinical Trial of Experimental Neuroendocrine Cancer Treatment

POPULAR CATEGORY

ABOUT US

FOLLOW US

Awards

No posts to display

Most Read

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

FOLLOW US